ABSTRACT
Plasma neurofilament light chain (NfL) is a marker of neuronal damage in different neurological disorders and might predict disease progression in dementia with Lewy bodies (DLB). The study enrolled 45 controls and 44 DLB patients (including 17 prodromal cases) who underwent an extensive assessment at baseline and at 2 years follow-up. At baseline, plasma NfL levels were higher in both probable DLB and prodromal cases compared to controls. Plasma NfL emerged as the best predictor of cognitive decline compared to age, sex and baseline severity variables. The study supports the role of plasma NfL as a useful prognostic biomarker from the early stages of DLB.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The recruitment of patients was partially supported by BIOMANE Project from the Health and Wealth research grants 2016 of the University of Brescia [grant number NP 1471, DMA].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the local ethics committee (NP 1471, DMA, Brescia, Italy).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authorship
Andrea Pilotto: study concept and design, acquisition of data, analysis and interpretation of data, drafting/revising the manuscript for content.
Alberto Imarisio: study concept and design, acquisition of data, analysis and interpretation of data, drafting/revising the manuscript for content.
Claudia Carrarini: acquisition of data, drafting/revising the manuscript for content.
Mirella Russo: acquisition of data, drafting/revising the manuscript for content.
Stefano Masciocchi: acquisition of data, drafting/revising the manuscript for content.
Stefano Gipponi: acquisition of data, drafting/revising the manuscript for content.
Elisabetta Cottini: acquisition of data, drafting/revising the manuscript for content.
Dag Aarsland: drafting/revising the manuscript for content.
Henrik Zetterberg: study concept and design, acquisition of data, analysis and interpretation of data, drafting/revising the manuscript for content.
Nicholas Ashton: acquisition of data, analysis and interpretation of data, drafting/revising the manuscript for content.
Abdul Hye: acquisition of data, analysis and interpretation of data, drafting/revising the manuscript for content.
Laura Bonanni: acquisition of data, analysis and interpretation of data, drafting/revising the manuscript for content.
Alessandro Padovani: acquisition of data, analysis and interpretation of data, drafting/revising the manuscript for content.
Data Availability
Data are available upon reasonable request to the corresponding Author.